AnGes Financial Statements From 2010 to 2024
AMGXF Stock | USD 0.41 0.00 0.00% |
Check AnGes financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AnGes' main balance sheet or income statement drivers, such as , as well as many indicators such as . AnGes financial statements analysis is a perfect complement when working with AnGes Valuation or Volatility modules.
AnGes |
AnGes Inc OTC Stock Shares Outstanding Analysis
AnGes' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current AnGes Shares Outstanding | 156.07 M |
Most of AnGes' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AnGes Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, AnGes Inc has 156.07 M of shares currently outstending. This is 13.55% lower than that of the Healthcare sector and 46.06% higher than that of the Biotechnology industry. The shares outstanding for all United States stocks is 72.71% higher than that of the company.
AnGes Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AnGes's current stock value. Our valuation model uses many indicators to compare AnGes value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AnGes competition to find correlations between indicators driving AnGes's intrinsic value. More Info.AnGes Inc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AnGes' earnings, one of the primary drivers of an investment's value.About AnGes Financial Statements
AnGes stakeholders use historical fundamental indicators, such as AnGes' revenue or net income, to determine how well the company is positioned to perform in the future. Although AnGes investors may analyze each financial statement separately, they are all interrelated. For example, changes in AnGes' assets and liabilities are reflected in the revenues and expenses on AnGes' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AnGes Inc. Please read more on our technical analysis and fundamental analysis pages.
AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan. Anges Mg is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in AnGes OTC Stock
AnGes financial ratios help investors to determine whether AnGes OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AnGes with respect to the benefits of owning AnGes security.